Status:
COMPLETED
ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis
Lead Sponsor:
Centre Hospitalier de Lens
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
COVID-19 is a worldwide pandemic. Around 5% of infected patients are admitted in ICU, mainly for respiratory failure. Outcome of these patients is linked to other organ failures. Optimal therapies are...
Eligibility Criteria
Inclusion
- Any adult patient admitted in the ICU with COVID-19 pneumonia
Exclusion
- Pregnancy
- Legal reasons (patients under guardianship, curatorship)
- Patient's refusal
Key Trial Info
Start Date :
July 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 29 2021
Estimated Enrollment :
183 Patients enrolled
Trial Details
Trial ID
NCT04522310
Start Date
July 7 2020
End Date
May 29 2021
Last Update
August 5 2021
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of Arras
Arras, France, 62000
2
Hospital of Boulogne/mer
Boulogne-sur-Mer, France, 62200
3
Hospital of DOUAI
Douai, France, 59507
4
Hospital of Dunkerque
Dunkirk, France, 59240